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Abstract 
Recent studies have suggested that autophagy is involved in a neural death pathway 
following cerebral ischemia. In vivo detection of autophagy could be important for evaluating 
ischemic neural cell damage for human stroke patients. Using novel green fluorescent protein 
(GFP)-fused microtubule-associated protein 1 light chain 3 (LC3) transgenic (Tg) mice, in 
vivo imaging of autophagy was performed at 1, 3, and 6 d after 60-min transient middle 
cerebral artery occlusion (tMCAO). Ex vivo imaging of autophagy, testing of the autophagy 
inhibitor 3-methyladenine (3-MA), Western blot analysis, immunohistochemistry, terminal 
deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick end labeling (TUNEL), and 
fluorescent analyses were performed on brain sections following tMCAO. In vivo fluorescent 
signals were detected above the ischemic hemisphere through the skull bone at 1, 3, and 6 d 
after tMCAO, with a peak at 1 d. Similar results were obtained with ex vivo fluorescence 
imaging. Western blot analysis revealed maximum LC3-I and LC3-II expression at 1 d after 
tMCAO, and fluorescence immunohistochemistry demonstrated that GFP-LC3-positive cells 
were primarily neuronal, not astroglial or microglial, cells. The number of GFP-LC3/TUNEL 
double-positive cells was greater in the peri-ischemic area than in the core. These results 
provided evidence of in vivo autophagy detection, with a peak at 1 d, in a live animal model 
following cerebral ischemia. This novel technique could be valuable for monitoring 
autophagic processes in vivo in live stroke patients, as well as for clarifying the detailed role 
of autophagy in the ischemic brain, as well as in other neurological diseases. 
 
 
 
 
 
 
 3 
 
Introduction 
Similar to the ubiquitin-proteasome system, autophagy is considered to play an 
important role in preventing accumulation of abnormal protein.1 There is increasing interest in 
being able to examine the relationship between autophagy and stroke. A very recent report 
showed that stroke could induce activation of autophagy.2 LC3 is a ubiquitin-like protein and 
is a useful marker of autophagy. LC3 is present in two different forms—one precursor that is 
cytosolic, LC3-I, and another that is phospholipid-conjugated, LC3-II.3 When autophagic 
stimulus takes place in a cell, LC3-I converts to LC3-II by conjugation of 
phosphatidylethanolamine (PE). LC3-II is then localized on phagophores, which ultimately 
develop into autophagosomes.4 The amount of LC3-II highly correlates with the number of 
autophagosomes3 and increases after hypoxia-ischemia, with a peak at 1 d.5 The protein 
p62/SQSTM1 is also associated with autophagosomes, after binding to LC3-II, and is 
therefore another marker that is utilized to study autophagy.6 
(GFP-LC3 transgenic mice were created by a transgenic vector containing an enhanced 
GFP (EGFP)-LC3 cassette inserted between the CAG promoter7 and the SV40 late poly A 
fragment. In these particular mice, GFP-LC3 is normally expressed in almost all tissues at a 
baseline level,8 but GFP-LC3 is also further induced under pathological conditions that 
activate autophagy.9 These mice can also be used for monitoring autophagy in the model of 
nutrient starvation.8 
There are at least three types of cell death mechanisms, namely, necrosis, apoptosis, and 
transcriptional repression-induced atypical death (TRIAD),10 with autophagy possibly 
representing a fourth type. Necrosis is the mechanism where the cell membrane looses its 
integrity and becomes leaky. Apoptosis is associated with nuclear and chromatin condensation, 
DNA fragmentation, organelle swelling, cytoplasmic vacuolization, and nuclear envelope 
disruption.11 TRIAD is related to general transcriptional repression, induces slowly 
progressive atypical cell death, and is also involved in neuronal death in Huntington disease 
and amyotrophic lateral sclerosis (ALS).10 Because apoptosis plays an important role in the 
neuronal cell death that occurs around the peri-ischemic area, it has attracted attention as the 
target of neuroprotective therapy. A recent report suggested a possible relationship between 
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autophagy and the apoptotic mechanism of cell death.5 However, there have been few reports 
that clearly examined such a relationship in the ischemic brain. 
In this study, therefore, we attempted to detect in vivo fluorescence imaging of 
autophagy in this particular mice model after transient cerebral ischemia, to identify the 
fluorescent signal in relation to autophagic markers in brain sections, and to analyze a 
possible relationship between autophagy and apoptosis. 
 
Materials and Methods [This section needs to be moved after the Discussion, and the 
citations renumbered accordingly.] 
GFP-LC3 Transgenic Mice 
We obtained GFP-LC3#53 mice from the RIKEN Bio-Resource Center in Japan and we 
maintained this line as homozygotes.9 A transgenic vector of the mice contains an EGFP-LC3 
cassette inserted between the CAG promoter (cytomegalovirus immediate-early (CMVie) 
enhancer and chicken β-actin promoter)7 and the SV40 late polyadenylation signal. In this 
construction, EGFP is fused to the N terminus of rat LC3B (U05784) so as not to affect 
C-terminal PE conjugation. The 3.4 kbp CAG-EGFP-LC3-SV40 poly A fragment was 
microinjected into C57BL/6NCrj BDF1 fertilized oocytes. The initial screen gave 8 
transgenic lines. One of them, GFP-LC3#53, was selected because GFP-LC3 was 
ubiquitously expressed in almost all tissues.8 The GFP-LC3 transgenic neonates could be 
distinguished from wild-type neonates using a portable GFP macroscope LEDB-3WOF 
(Optocode, Japan).9 
In the GFP-LC3 Tg mice, GFP-LC3 localizes only on autophagic membranes but not on 
other membrane structures3 and the GFP-LC3 signal could be detected specifically by the 
GFP or FITC filter set but not by others.9 When autophagy was induced, the number of 
GFP-LC3 dots (autophagosomes) observed by microscopy generally increased in vivo.8 
 
The model of transient middle cerebral artery occlusion 
The GFP-LC3 8 week old male mice, weighing 20-23 g, were anesthetized with a 
nitrous oxide:oxygen:isoflurane mixture (69%:30%:1%) during surgical preparation. The 
right common carotid artery was isolated and an 8-0 nylon thread with silicon-coated tip was 
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inserted into the right MCA and gently advanced (9.0-10.0 mm). At 60 min after the MCAO, 
the nylon thread was withdrawn and ischemic brain tissue was reperfused. During the surgery, 
body temperature was monitored and maintained in the range of 37 ± 0.3°C. Regional 
cerebral blood flow (CBF) was measured in the ischemic area (1 mm posterior and 3 mm 
lateral to the bregma) using a laser-Doppler flowmeter (Omegawave, FLO-C1), at the 
baseline, time point of inducing of ischemia, 5 and 10 min after ischemia, and 5 min after the 
reperfusion, as described in detail previously.12,13 The values of CBF are represented as a 
percentage of baseline. After the incision was closed, the animals recovered and were allowed 
free access to water and food at ambient temperature until sampling. The experimental 
protocol and procedure were approved by the Animal Committee of the Graduate School of 
Medicine and Dentistry, Okayama University. 
 
Imaging System and In vivo imaging 
For the in vivo imaging, we used an Olympus MVX10 in vivo imaging system 
(Olympus, MVX10) equipped with dual objective (0.63x, 2x), U-RFL-T 100W mercury lamp 
(Olympus, U-RFL-T), and ORCA-R2 charge-coupled device camera (Hamamatsu photonics, 
C10600-10B), and image analysis software MetaMorph (Molecular Devices, Version 7.5). 
In vivo imaging of autophagy in brain ischemia of GFP-LC3 transgenic mice was 
performed on day 1, 3 and 6 (n=7 in 1 d, n=5 in 3 and 6 d) after 60 min of tMCAO. Animals 
were anesthetized with a nitrous oxide:oxygen:isoflurane mixture, then the head skin was cut 
and removed for in vivo detection of GFP light through the parietal bone. The animals were 
fixed and the body temperature was monitored and maintained in the range of 37 ± 0.3°C 
inside the Olympus MVX10 system. An in vivo imaging signal was obtained with 0.63x zoom 
1. An intensity-controlled laser diode was used for emitting at 488 nm, and the U-MGFP was 
used at 505 nm interference filter (Olympus, U-MGFP/XL) for the detection of the 
fluorescence emission and blocking the excitation light. Fluorescence emission was collected 
by an ORCA-R² digital CCD camera, with exposure time of 300 ms. Image analysis was 
performed using the abovementioned software MetaMorph. 
 
Ex vivo imaging 
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After obtaining in vivo imaging signals at 1, 3 and 6 d, the same mice were anesthetized 
with an overdose of pentobarbital (40 mg/kg) and perfused through the heart with 20 ml of 
ice-cold heparinized saline. The brains were then removed and rapidly frozen in powdered 
dry ice. The mice brains were cut on a cryostat into 20-µm thick sections at -18ºC and 
collected on silanized slides (Dako, S3003). The fluorescence of GFP was detected ex vivo in 
the ischemic area with an Olympus MVX10 using the same condition as for in vivo imaging. 
Ex vivo images were then analyzed by pseudocolor capture. 
 
Immunohistochemistry 
The brain sections were washed with phosphate-buffered saline (PBS; pH 7.4), and then 
blocked for 2 h in 10% normal goat serum (NGS) (Funakoshi, 2v-0002-10), 
Tris-NaCl-blocking buffer (TNB) (p62 stain) (Perkin Elmer, 376801) and 0.1% Triton X-100 
in PBS. Then they were incubated overnight at 4°C with the primary antibody in 10% NGS, 
TNB and 0.1% Triton X-100 in PBS. On the next day, the slices were washed in PBS, and 
incubated for 2 h with fluorochrome-coupled secondary antibody (Alexa Fluor™, Molecular 
Probes, A21424, A21429) at room temperature. The sections were then rinsed three times in 
PBS and mounted with VECTASHIELD®Mounting Medium with DAPI (Vector 
Laboratories, H1200). A confocal microscope equipped with argon and HeNe1 lasers (Zeiss, 
LSM 510) was used to capture fluorescent images. The primary antibodies in this study were 
as follows: anti-microtubule-associated protein 1 light chain 3 (LC3; 1:400; MBL, PM036), 
anti-SQSTM1/A170/p62 (1:400; Wako, 018-22141), anti-NeuN (1:400; Chemicon, MAB377), 
anti-GFAP (1:400; Chemicon, MAB3402), anti-Iba1 (1:400; Wako, 019-19741), and 
anti-cleaved caspase-3 (1;400; Cell signaling, 9661). 
 
Western blot analysis 
Western blot analysis was performed using the ischemic hemisphere of three mice from 
each group. Animals were anesthetized with an overdose of pentobarbital (40 mg/kg) and 
perfused through the heart with 20 ml of ice-cold heparinized saline. The brains were then 
removed and the brain tissues were collected from the ischemia area. Then 0.3 mL of cold 
lysis buffer (50 mM Tris–HCl, pH 7.2, 10% glycerol, 250 mM NaCl, 0.1% NP-40, 2 mM 
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EDTA and protease inhibitors) was added to each tube, and it was homogenized at 4°C. The 
homogenate was centrifuged at 12,000 rpm at 4°C for 10 min, and the supernatant fractions 
(S1) were collected. Protein concentrations of the S1 samples were determined by Lowry 
assay (Amersham Biosciences, Ultrospec 3100 pro). An amount equivalent to 2 µg of total 
protein for each sample was subjected to 14% polyacrylamide gel electrophoresis and 
transferred to polyvinylidene difluoride membranes (Millipore, IPVH00010). The membrane 
was blocked with 5% skimmed milk Tween PBS (skimmed-milk 5 g, 100 ml PBS, pH 7.4, 
0.1% Tween [Which Tween? Tween-20?]). We carried out western blot analysis using 
standard techniques with an ECL plus detection kit (GE Healthcare, RPN 2132) according to 
our previous report.14, 15 The primary antibodies in this study were as follows: anti-LC3 (1:500; 
MBL, PM036), anti-SQSTM1/A170/p62 (1:200), anti-GFP (1:2,500; MBL, 598), anti-Beclin 
1 (1:500; BD，612113), and anti-cleaved caspase-3 (1:1,000). We carried out densitometry 
analysis using Scion Image Beta 4.02 software and took the average of the three mice.  
 
Cell count 
To quantitatively evaluate the results of single immunofluorescence analysis and 
TUNEL fluorescence, the number of positive cells was counted for NeuN, GFAP, Iba1, and 
TUNEL in the cortex core and peri-ischemic area of the cerebral cortex, in five coronal 
sections. In the double fluorescence studies, the double-positive cells were counted in the 
same manner. 16 
 
Terminal deoxynucleotidyltransferase-mediated dUTP-digoxigenin nick end labeling 
fluorescence 
TUNEL assay was performed using an in situ cell death detection kit, TMR red 
(Roche, 2156792) according to the manufacturer's instructions. First, the sections were 
washed with PBS (10 min, 3 times), they were then incubated with reaction mixture for 60 
min at 37°C. The signals were examined using a confocal microscope (Zeiss, LSM 510). The 
TUNEL fluorescence-positive cells at the ischemic boundary zone were counted using 5 
sections from one brain. 
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Testing of 3-Methyladenine 
3-methyladenine was obtained from Sigma (Sigma, M9281). Intracerebroventricular 
(icv) injections were given in the ipsilateral ventricle with 2 µl of a 30 mg/ml solution 
prepared in saline (0.9% NaCl). Mice were injected at the beginning of reperfusion (n = 4) 
and sampling was done at 1 d after tMCAO.17 
 
Statistical Analysis 
Results are shown as the mean ± SD. Obtained data were analyzed by Student's t-test. A 
probability value of <0.05 was considered statistically significant. 
 
Results 
Monitoring in vivo autophagy after tMCAO in GFP-LC3 transgenic mice 
A fluorescence imaging analyzer detected no fluorescent signal in the hemispheres in 
vivo on sham-operated head (Fig. 1A, a). At 1 d of reperfusion after the tMCAO, a fluorescent 
signal was strongly observed over the head of the ischemic hemisphere (Fig. 1A, b). At 3 and 
6 d after the tMCAO, the in vivo fluorescence was still detected over the head of the ischemic 
hemisphere, but the fluorescent signal gradually faded from 1 to 6 d after the reperfusion (Fig. 
1A, b-d). 
 
Ex vivo autophagy imaging of cerebral slices 
Ex vivo autophagy imaging of cerebral slices showed that the fluorescent signal was 
scarcely visible in 20-µm cerebral slices from the sham-operated brain (Fig. 1A, e, i), whereas 
the highest fluorescent signal intensities were detected in the lateral cerebral cortex and 
striatum (Fig. 1A, f, arrows) of the ischemic hemisphere at 1 d after the tMCAO, with gradual 
decrease from 3 to 6 d after the tMCAO (Fig. 1A, g-h, arrows). These changes were 
demonstrably shown in a coloring graded image (Fig. 1A, i-l). With microscopy examination, 
fluorescence was slightly detected in the sham-operated cerebral cortex and in the 
peri-ischemic area of the ischemic cortex (Fig. 1A, m, q). After the tMCAO, such fluorescent 
signals became progressively weaker at 1 and 3 d, and finally disappeared at 6 d in the 
ischemic core of the cerebral cortex (Fig. 1A, n-p). On the other hand, the fluorescent signal 
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was strongly induced at 1 d after the tMCAO in neural cells of the peri-ischemic area (Fig. 1A, 
r), which then gradually decreased until 3 and 6 d (Fig. 1A, s-t). 
 
Double immunofluorescence with GFP-LC3 and autophagosome marker 
For double immunofluorescence analysis, anti-LC3 and anti-p62 antibodies were used 
as the markers of autophagosomes. Fig. 1B shows data of colocalization of GFP-LC3 
fluorescence and anti-LC3 in neural cells of the peri-ischemic area, both with the peak at 1 d 
after tMCAO. In detail, both GFP (green) fluorescence, which represents intrinsic signal, and 
LC3 (red) fluorescence, which represents exogenously added antibody, showed many dot 
signals in the cytoplasm and those merged well. Fig. 1C shows data of colocalization of 
GFP-LC3 fluorescence and anti-p62 in neural cells of the peri-ischemic area. The peak of the 
dots of GFP-LC3 was at 1 d after tMCAO. However, the p62 (red) fluorescent signal was 
reduced at 1 d after tMCAO compared to the sham-treated cells. 
 
Western blot analysis  
Results of western blot analysis are shown in Fig. 2A (a-d) and Fig. 3B, b. In Fig. 2A, a 
sham brain, only a single band of LC3-I was detectable with antibody against LC3, but the 
band of LC3-II was scarcely detectable. Both LC3-I and LC3-II were induced and reached the 
maximum at 1 d after tMCAO, and then gradually returned to the sham level by 6 d. 
GFP-LC3 essentially follows the same process (Fig. 2A, a). At 1 d after tMCAO, the band of 
Beclin 1 reached the maximum (Fig. 2A, c; p<0.01). On the other hand, only a reduction of 
band intensity for p62 was detectable at 1 d with antibody against p62 (Fig. 2A, b; p<0.01). In 
contrast, the amount of β-tubulin remained at a constant level among sham-treated samples at 
1, 3 and 6 d after tMCAO. The band of GFP-LC3-II was significantly blunted by 3MA (Fig. 
2A, d; p<0.01). As an apoptotic marker, the band of cleaved caspase-3 was strongly induced 
at 3 d after tMCAO (Fig. 3B, b; p<0.01)  
The LC3-I and LC3-II levels reached maximum at 1 d after tMCAO (Fig. 2A, a; 
*p<0.05, **p<0.01). 
 
Double immunofluorescence with GFP-LC3 and neural markers 
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In brain sections at 1 d after tMCAO, both NeuN and GFAP showed many 
double-positive cells but not in the sham-treated brains (Fig. 2B, upper 12 panels). In contrast, 
Iba1 immunostaining showed few positive cells 1 d after tMCAO in the ischemic area (Fig. 
2B, bottom 3 panels). 
 
Number of autophagy-positive cells after tMCAO 
The number of double-positive cells with GFP-LC3 (autophagy) and the markers for 
neuronal, astrocytic, or microglial cells in the ischemic core and peri-ischemic area of the 
affected cerebral hemisphere are shown in Fig. 2C. The number of NeuN-positive cells was 
143.3 ± 53.0 in the ischemic core and 314.1 ± 41.8 in the peri-ischemic area, that of GFAP 
were 49.6 ± 23.1 and 143.3 ± 62.8, Iba1 were 38.6 ± 15.1 and 60.6 ± 23.1. 
The double fluorescence study showed many GFP-LC3-positive NeuN cells in 
comparison with GFP-LC3-positive GFAP cells in the ischemic area (Fig 2C, **p<0.05, 
**p<0.01, #p<0.05, ##p<0.01). 
 
Relations of autophagy and apoptosis after tMCAO 
Fig. 3 shows a double immunofluorescence analysis with GFP-LC3 and markers of 
apoptosis (TUNEL, cleaved caspase-3). At 1 d after tMCAO, double-positive cells were 
observed in a small number of neural cells in the ischemic core and in a large number in the 
peri-ischemic area (Fig. 3A, arrowheads). In quantitative analysis, the numbers of 
single-positive cells for GFP-LC3 (autophagy) and TUNEL (apoptosis) in the cortex of the 
ischemic core and peri-ischemic area, respectively, at 1 d after tMCAO in the ischemic core 
were 122.6 ± 65.8 and 1,458.3 ± 355.4, and in the peri-ischemic area were 453.4 ± 57.0 and 
465.7 ± 65.8. 
Double-positive cells with GFP-LC3 and TUNEL were 61.3 ± 36.4 in the ischemic core 
and 245.1 ± 53.7 in the peri-ischemic area (Fig. 3B, *p<0.05, **p<0.01). The double-positive 
cells for GFP-LC3 and cleaved caspase-3 were also observed in the ischemic area (Fig 3B, a 
arrowheads). 
 
Discussion 
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This is the first report monitoring autophagy in vivo after tMCAO in mice (Fig. 1A). A 
fluorescent signal was strongly observed over the head of the ischemic hemisphere after 
tMCAO. This fluorescent signal was detected by the GFP or FITC filter set, but could not be 
detected using a Cy5 fluorescence filter (data not shown), suggesting that the fluorescent 
signal actually is related to autophagy. The peak of the in vivo fluorescence signal was at 1 d 
after tMCAO, and became gradually weaker from 3 d after tMCAO (Fig. 1A, a-d). This result 
was confirmed by the examination of ex vivo autophagy imaging of tMCAO (Fig. 1A, e-t) 
showing the same chronological changes.  
It was reported that the level of GFP-LC3 was comparable to that of endogenous LC3 
expression in the brain in GFP-LC3 Tg mice.9 Autophagosomes were labeled with GFP-LC3 
during autophagy induction in Tg mice.18 This phenomenon could be observed by 
fluorescence microscopy.8 Baseline autophagy can be detected in a very small number of 
GFP-LC3 dots (autophagosomes), but can be further detected in an increasing number of 
small dots when autophagy is actively induced.8 In our study, the findings from in vivo 
imaging suggest that the in vivo fluorescence signal (Fig. 1A, a-d) is related to the formation 
of the GFP-LC3 dots that are increased in the ischemic cerebral hemisphere (Fig. 1B, C). In 
our study, both the intrinsic GFP fluorescence signal and exogenously added antibody of LC3 
merged well (Fig. 1B), and in the previous study, it was confirmed that autophagosomes 
correlate with the GFP signal in the same Tg mice based on electron microscopy.8 This means 
that the fluorescent signal observed in our study is actually the signal reflecting 
autophagosome formation.  
In the previous studies it is shown that 3MA can inhibit the autophagic process17. In our 
study GFP-LC3-II expression in the ischemic area was clearly decreased by treatment with 
3MA compared to treatment with saline at 1 d after tMCAO. In addition, it was reported that 
p62 is degraded in autophagosomes, 19 and therefore it is thought that the level of p62 reflects 
the autophagic status. In our study the amount of p62 clearly decreased at 1 d after tMCAO 
(Fig. 3A,b) [I do not see where this is shown in Fig. 3A,b.]. In addition, immunofluorescence 
showed the same result. These findings also suggest that autophagy is stimulated after 
cerebral ischemia. However, the level of p62 was increased at 3 and 6 d after tMCAO, 
suggesting perhaps that autophagy is upregulated to protect the damaged neurons or that 
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delaying the clearance of autophagosomes causes an increase in components of 
autophagosomes like p62 (Fig. 1C). LC3 is associated with autophagosome membranes after 
posttranslational modifications. A C-terminal fragment of LC3 is cleaved immediately after 
synthesis to yield a cytosolic form called LC3-I. A subpopulation of LC3-I is further 
converted to an autophagosome-associating form, LC3-II. The amount of LC3-II correlates 
with the extent of autophagosomes formation.3,20 Thus, the conversion of LC3-I into LC3-II is 
accepted as a simple method for monitoring autophagy.8,21 Beclin 1 was strongly enhanced in 
autophagic neurons.22 In our study, we detected the increase of LC3-I, LC3-II and Beclin 1 
after tMCAO with western blot analysis with a peak at 1 d (Fig. 2A). These findings suggest 
the autophagic pathway is activated after tMCAO; concomitantly, expression of LC3-I may 
increase as a result of upregulation of autophagy. 
 Previous reports show that autophagy can be induced in neurons in the tMCAO 
model2. Activation of autophagy increases not only in neurons but also in astrocytes and 
vascular endothelial cells after tMCAO.2 Our present study showed an activation of 
autophagy both in neurons and astrocytes, but not in microglial cells (Fig. 2B). The number of 
autophagy-induced cells in the peri-ischemia area was greater than in the area of the ischemic 
core, and the number of autophagy-induced neurons was about 2 times higher compared to 
the number of autophagic astrocytes at 1 d after tMCAO (Fig. 2C). These results suggest that 
there are many neurons displaying autophagy in the peri-ischemic area, while many neurons 
also show apoptosis, implying a relationship between autophagy and apoptosis. 
The level of LC3-II reached the maximum in the area of the ischemic cortex and 
hippocampus at 6-24 h after cerebral ischemia.5 The number of TUNEL-positive cells reached 
a peak in the area of the ischemic cortex at 24-48 h after cerebral ischemia.23,24 In our study, 
although the peak of apoptosis was at 3 d after tMCAO (Fig 3B, b), autophagy-positive cells 
were present mainly in the peri-ischemic area, and apoptosis-positive cells mainly in the area 
of the ischemic core at 1 d after tMCAO (Fig. 3B). Furthermore, the number of apoptotic cells 
was greater than the autophagic cells in the ischemic area at 1 d after tMCAO, suggesting that 
autophagy could be induced in earlier stages after tMCAO compared to apoptotis.  
Autophagic and apoptotic mechanisms could occur in the same injured neuron,25 
autophagy may inhibit apoptosis,26 or autophagy may promote apoptosis.5 LC3/TUNEL 
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double-positive cells were observed in the ischemic area after tMCAO.2 In our study, the 
GFP-LC3/TUNEL and GFP-LC3/cleaved caspase-3 double-positive cells were observed in 
the core and peri-ischemic area after tMCAO (Fig. 3A, B). The number of GFP-LC3 and 
TUNEL double-positive cells in the peri-ischemic area was about 4 times higher compared to 
the ischemic core at 1 d after tMCAO (Fig. 3B). This result suggests that apoptotic and 
autophagic cell death pathways could occur in the same cells. On the other hand, it was 
reported that apoptosis would be induced when autophagy was inhibited in neurons,27 and if 
autophagy is blocked, the cell might quickly proceed towards necrosis by interrupting the 
apoptotic program which is simultaneously active.28 These result suggests that the autophagic 
pathway has protective affects against apoptotic cell death and necrosis. However, others 
report that a sustained high level of autophagy could also lead to cell death.5 In future studies 
the relationship among autophagy, apoptosis and necrosis should be clarified. 
In conclusion, this study showed a way of detecting in vivo autophagy in a live animal 
model. This method could be used as a novel technique for clarifying the role of autophagy 
not only in the ischemic brain but also in the other neurological diseases. The co-existence of 
autophagic and apoptotic cell death pathways, found in this study, may be important to define 
the mechanism of neuronal cell death after tMCAO, and to find a better therapy for ischemic 
stroke patients in the future. 
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Figure legends 
 
Figure 1. Monitoring of GFP-fluorescent signal with the observation of (A, a-d) in vivo 
imaging over the head of the ischemic hemisphere. (A, e-h) Ex vivo imaging in 20-µm 
cerebral slices from the same brain at 1, 3 and 6 d after tMCAO. (A, i-l) Results of ex vivo 
imaging were shown as pseudocolor. (A, m-t) Observation of GFP-fluorescence of neuron 
with microscopy in the core and peri-ischemic area of the ischemic cortex. (B) Double 
immunofluorescence with GFP-LC3 and autophagosome markers anti-LC3 (red), (C) and 
anti-p62 (red). Bar 3µm. [Change the label in panel A to “peri-ischemic” with a hyphen.] 
 
[Put Figure 2 and Figure 3 on separate pages and increase the font size for both so that the 
labels are easier to read.] 
Figure 2. (A, a-c) Western blot of GFP-LC3, LC3, p62, Beclin 1 and β-tubulin, and ratios of 
LC3/β-tubulin at 1, 3 and 6 d after tMCAO. (A, d) Testing of the 3MA. (B) Double 
immunofluorescence with GFP-LC3 and neuronal (NeuN), astrocytic (GFAP), and microglial 
(Iba1) markers. (C) Number of autophagy-positive cells after tMCAO. Bar, 3 µm. [Change 
“beclin-1” to “Beclin 1” with no hyphen, but with a space and capitalized “B”.] 
 
Figure 3. (A, a) Double immunofluorescence with GFP-LC3 and TUNEL. (A, b) Number of 
TUNEL and GFP-LC3 double-positive cells at 1 d after tMCAO. (B, a) Double 
immunofluorescence with GFP-LC3 and cleaved caspase-3. (A, a-c) Western blot of cleaved 
caspase-3, β-tubulin, and ratios of cleaved caspase-3/β-tubulin at 1, 3 and 6 d after tMCAO. 
Bar, 3 µm. 
 
 



